Aprotinin in coronary operation with cardiopulmonary bypass: does “low-dose” aprotinin inhibit the inflammatory response?

This publication has 28 references indexed in Scilit:

• Reducing the Post-Pump Syndrome by Using Heparin-Coated Circuits, Steroids, or Aprotinin
  The Thoracic and Cardiovascular Surgeon, 1999
• Does the Duration of Cardiopulmonary Bypass or Aortic Cross-Clamp, in the Absence of Blood and/or Blood Product Administration, Influence the IL-6 Response to Cardiac Surgery?
  Anesthesia & Analgesia, 1998
• Effects of minimal-dose aprotinin on coronary artery bypass grafting
  The Journal of Thoracic and Cardiovascular Surgery, 1997
• “Low-Dose” Aprotinin Modifies Hemostasis but Not Proinflammatory Cytokine Release
  The Annals of Thoracic Surgery, 1997
• Aprotinin for Primary Coronary Artery Bypass Grafting: A Multicenter Trial of Three Dose Regimens
  The Annals of Thoracic Surgery, 1996
• Influence of low-dose aprotinin on the inflammatory reaction due to cardiopulmonary bypass in children
  The Annals of Thoracic Surgery, 1996
• Aprotinin
  Drugs, 1995
• Neutrophil Lactoferrin Release During Open Heart Surgery Is Unrelated to Complement Activation
  Asaio Journal, 1994
• The prolonged activated clotting time (ACT) with aprotinin depends on the type of activator used for measurement
  Blood Coagulation & Fibrinolysis, 1993
• Low-dose aprotinin for reduction of blood loss after cardiopulmonary bypass
  The Lancet, 1991